{"id":9139,"date":"2026-04-21T15:47:41","date_gmt":"2026-04-21T13:47:41","guid":{"rendered":"https:\/\/www.kedrion.it\/?post_type=our_stories&#038;p=9139"},"modified":"2026-04-21T18:26:02","modified_gmt":"2026-04-21T16:26:02","slug":"putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy","status":"publish","type":"our_stories","link":"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/","title":{"rendered":"Putting patients first: priorities for Congenital Bleeding Disorders in Italy"},"content":{"rendered":"\n<div class=\"container ourStorySingleBlockBanner\">\n    <div class=\"row\">\n        <div class=\"col-lg-6 col-lg-offset-4\">\n            <div class=\"single-story__intro_banner\">\n                <span>#PatientFirst<\/span>\n                <p>In the field of Congenital Bleeding Disorders, progress holds real value only when it translates into tangible improvements in patients\u2019 lives. This means protecting rights, ensuring access to appropriate care, and making sure that the needs of the community are represented where decisions are made. In Italy, this is the role FedEmo has carried forward for 30 years on behalf of people living with rare bleeding disorders.<\/p>\n<p>Cristina Cassone, President of FedEmo, outlines the priorities shaping this commitment today. A key focus is protecting the safeguards and benefits achieved over time for people living with Congenital Bleeding Disorders, ensuring that no one is excluded from the support and care they need because of their condition.<\/p>\n<p>Another urgent priority is preserving the quality of care in treatment centers. For <strong>World Hemophilia Day 2026<\/strong>, FedEmo emphasized the need to recognize and strengthen the role of healthcare professionals specialized in hemostasis and thrombosis. Their presence remains essential to guaranteeing the dedicated, expert care that patients rely on today and will continue to need in the future.<\/p>\n<p><em>\u201cWe look to younger generations, but we also want to protect those who have devoted themselves full-time to these disorders up to now.\u201d<\/em><br \/>\nCristina Cassone, President, FedEmo<\/p>\n<p>This long-term vision also takes shape through Scuola FedEmo, a training initiative created to support young members from local associations and help them develop the skills needed to represent the community effectively.\u00a0By investing in education and advocacy, FedEmo is helping build a stronger future for patient representation at both national and international level.<\/p>\n<p>At the center of all these priorities is one clear principle: patients must remain at the heart of every action. By turning representation into impact, and advocacy into concrete progress, FedEmo continues to work toward a future where every person living with a Congenital Bleeding Disorder can count on dedicated care, stronger protection, and timely access to treatment.<\/p>\n<p>As every year on World Hemophilia Day, which is celebrated worldwide on April 17th, Kedrion renewed its commitment to take care of patients, in addition to supporting their families and associations.<\/p>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n\n","protected":false},"featured_media":9136,"parent":0,"menu_order":0,"template":"our_stories\/stories_video.php","categories_our_stories":[],"class_list":["post-9139","our_stories","type-our_stories","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Putting patients first: priorities for Congenital Bleeding Disorders in Italy - Kedrion Biopharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Putting patients first: priorities for Congenital Bleeding Disorders in Italy - Kedrion Biopharma\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/\" \/>\n<meta property=\"og:site_name\" content=\"Kedrion Biopharma\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-21T16:26:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.kedrion.it\/wp-content\/uploads\/2026\/04\/ai-macro15.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1680\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/\",\"url\":\"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/\",\"name\":\"Putting patients first: priorities for Congenital Bleeding Disorders in Italy - Kedrion Biopharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.kedrion.it\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.kedrion.it\/wp-content\/uploads\/2026\/04\/ai-macro15.jpg\",\"datePublished\":\"2026-04-21T13:47:41+00:00\",\"dateModified\":\"2026-04-21T16:26:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/#primaryimage\",\"url\":\"https:\/\/www.kedrion.it\/wp-content\/uploads\/2026\/04\/ai-macro15.jpg\",\"contentUrl\":\"https:\/\/www.kedrion.it\/wp-content\/uploads\/2026\/04\/ai-macro15.jpg\",\"width\":1680,\"height\":960},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.kedrion.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our Stories\",\"item\":\"https:\/\/www.kedrion.it\/our-stories\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Putting patients first: priorities for Congenital Bleeding Disorders in Italy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.kedrion.it\/#website\",\"url\":\"https:\/\/www.kedrion.it\/\",\"name\":\"Kedrion Biopharma\",\"description\":\"Plasma-Derived Medicinal Products | Keep Life Flowing\",\"publisher\":{\"@id\":\"https:\/\/www.kedrion.it\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.kedrion.it\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.kedrion.it\/#organization\",\"name\":\"Kedrion S.p.A.\",\"url\":\"https:\/\/www.kedrion.it\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.kedrion.it\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.kedrion.it\/wp-content\/uploads\/2021\/04\/Logo-Kedrion-yellow-1.jpg\",\"contentUrl\":\"https:\/\/www.kedrion.it\/wp-content\/uploads\/2021\/04\/Logo-Kedrion-yellow-1.jpg\",\"width\":1772,\"height\":870,\"caption\":\"Kedrion S.p.A.\"},\"image\":{\"@id\":\"https:\/\/www.kedrion.it\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Putting patients first: priorities for Congenital Bleeding Disorders in Italy - Kedrion Biopharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/","og_locale":"en_US","og_type":"article","og_title":"Putting patients first: priorities for Congenital Bleeding Disorders in Italy - Kedrion Biopharma","og_url":"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/","og_site_name":"Kedrion Biopharma","article_modified_time":"2026-04-21T16:26:02+00:00","og_image":[{"width":1680,"height":960,"url":"https:\/\/www.kedrion.it\/wp-content\/uploads\/2026\/04\/ai-macro15.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/","url":"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/","name":"Putting patients first: priorities for Congenital Bleeding Disorders in Italy - Kedrion Biopharma","isPartOf":{"@id":"https:\/\/www.kedrion.it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/#primaryimage"},"image":{"@id":"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.kedrion.it\/wp-content\/uploads\/2026\/04\/ai-macro15.jpg","datePublished":"2026-04-21T13:47:41+00:00","dateModified":"2026-04-21T16:26:02+00:00","breadcrumb":{"@id":"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/#primaryimage","url":"https:\/\/www.kedrion.it\/wp-content\/uploads\/2026\/04\/ai-macro15.jpg","contentUrl":"https:\/\/www.kedrion.it\/wp-content\/uploads\/2026\/04\/ai-macro15.jpg","width":1680,"height":960},{"@type":"BreadcrumbList","@id":"https:\/\/www.kedrion.it\/en\/our-stories\/putting-patients-first-priorities-for-congenital-bleeding-disorders-in-italy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.kedrion.it\/en\/"},{"@type":"ListItem","position":2,"name":"Our Stories","item":"https:\/\/www.kedrion.it\/our-stories\/"},{"@type":"ListItem","position":3,"name":"Putting patients first: priorities for Congenital Bleeding Disorders in Italy"}]},{"@type":"WebSite","@id":"https:\/\/www.kedrion.it\/#website","url":"https:\/\/www.kedrion.it\/","name":"Kedrion Biopharma","description":"Plasma-Derived Medicinal Products | Keep Life Flowing","publisher":{"@id":"https:\/\/www.kedrion.it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kedrion.it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.kedrion.it\/#organization","name":"Kedrion S.p.A.","url":"https:\/\/www.kedrion.it\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.kedrion.it\/#\/schema\/logo\/image\/","url":"https:\/\/www.kedrion.it\/wp-content\/uploads\/2021\/04\/Logo-Kedrion-yellow-1.jpg","contentUrl":"https:\/\/www.kedrion.it\/wp-content\/uploads\/2021\/04\/Logo-Kedrion-yellow-1.jpg","width":1772,"height":870,"caption":"Kedrion S.p.A."},"image":{"@id":"https:\/\/www.kedrion.it\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.kedrion.it\/en\/wp-json\/wp\/v2\/our_stories\/9139","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kedrion.it\/en\/wp-json\/wp\/v2\/our_stories"}],"about":[{"href":"https:\/\/www.kedrion.it\/en\/wp-json\/wp\/v2\/types\/our_stories"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.kedrion.it\/en\/wp-json\/wp\/v2\/media\/9136"}],"wp:attachment":[{"href":"https:\/\/www.kedrion.it\/en\/wp-json\/wp\/v2\/media?parent=9139"}],"wp:term":[{"taxonomy":"categories_our_stories","embeddable":true,"href":"https:\/\/www.kedrion.it\/en\/wp-json\/wp\/v2\/categories_our_stories?post=9139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}